Topline Capital Management’s Cytek Biosciences CTKB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$17.8M	Buy	5,231,260 +3,760,485	+256%	+$12.8M	3.05%	12
2025 Q1	$5.9M	Buy	1,470,775 +1,234,179	+522%	+$4.95M	1.35%	18
2024 Q4	$1.54M	Buy	+236,596	New	+$1.54M	0.29%	29